Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
5.77
+0.10 (1.76%)
At close: Feb 21, 2025, 4:00 PM
5.81
+0.04 (0.69%)
After-hours: Feb 21, 2025, 5:21 PM EST
Anbio Biotechnology Revenue
Anbio Biotechnology had revenue of $5.85M in the half year ending June 30, 2024, a decrease of -67.21%. This brings the company's revenue in the last twelve months to $9.50M, up 8.43% year-over-year. In the year 2023, Anbio Biotechnology had annual revenue of $6.71M, down -71.49%.
Revenue (ttm)
$9.50M
Revenue Growth
+8.43%
P/S Ratio
25.68
Revenue / Employee
$351,928
Employees
27
Market Cap
253.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 6.71M | -16.83M | -71.49% |
| Dec 31, 2022 | 23.54M | 19.12M | 431.67% |
| Dec 31, 2021 | 4.43M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNNNN News
- 48 minutes ago - U.S. IPO Weekly Recap: IPO Calendar Slows Down With Small Listings - Seeking Alpha
- 1 day ago - Anbio Biotechnology Announces Closing of Initial Public Offering - GlobeNewsWire
- 3 days ago - Anbio Biotechnology Announces Pricing of Initial Public Offering - GlobeNewsWire
- 7 weeks ago - U.S. IPO Weekly Recap: 2 Microcaps List As More Small Issuers File For Listings - Seeking Alpha
- 7 weeks ago - Anbio Biotechnology Pursues U.S. IPO For Its IVD Products Launch - Seeking Alpha
- 7 weeks ago - Anbio Biotechnology IPO Registration Document (F-1) - SEC